Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT00386802
Brief Summary:
Primary purpose: Frequency of use of broad-spectrum antifungals in the episode of neutropenia.
Secondary purposes:To determine the safety and toxicity measure by:
1. Frequency of Invader Fungal Infection.
2. Frequency of global use of broad-spectrum antifungals as amphotericine, itraconazole, voriconazole, caspofungin, terbinafine, during the period of study.
3. Mortality
4. Development of nephrotoxicity
5. Use of galactomannan in this clinical context
6. Time of administration of empirical antifungal therapy of broad-spectrum.
Detailed Description:
Clinical trial with a pharmaceutical speciality in the conditions of authorized use
Study:
NCT00386802
Study Brief:
Protocol Section:
NCT00386802